До недавнего времени среди фармакологических средств, используемых для защиты желудочно-кишечного тракта (ЖКТ) от негативного влияния противоревматиче-ских препаратов, практически безраздельно господство-вали ингибиторы протонной помпы (ИПП). Сегодня, с появлением нового мощного препарата для гастро-и эн-
Prevention of gastrointestinal tract (GIT) complications is the most important element for the rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin (LDA). Proton pump inhibitors (PPIs) have long been the only medication to prevent these complications. However, PPIs are only effective in preventing and treating upper GIT diseases (NSAID gastropathy) rather than small intestinal injury (NSAID enteropathy
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.